— Know what they know.
Not Investment Advice

VECT NASDAQ

VectivBio Holding AG
1W: -0.4% 1M: +1.5% 3M: +93.7% 1Y: +182.7%
$16.87
Last traded 2023-07-07 — delisted
NASDAQ · Healthcare · Biotechnology · $1.1B mcap

Cash Flow Trends

Operating Cash Flow
-$56M +22.0% ▲
Capital Expenditures
$74K -29.8% ▼
3Y CAGR: +9.7%
Free Cash Flow
-$56M +22.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$5K +0.0% ▲
Net Change in Cash
$119M +89.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$23M-$60M-$87M-$94M
Depreciation & Amort.$152K$270K$303K$239K
Stock-Based Comp.$2M$5M$25M$17M
Change in Working Capital$5M$2M$1M$9M
Other Non-Cash Items$2M$14M-$11M$11M
Operating Cash Flow-$15M-$38M-$72M-$56M
— Investing Activities —
Capital Expenditures-$56K-$93K-$57K-$74K
Acquisitions (Net)$0$0-$1M$0
Investment Purchases-$4K-$7K$0$0
Investment Sales$0$0$0$0
Other Investing$15K$31K-$5M$0
Investing Cash Flow-$45K-$69K-$7M-$74K
— Financing Activities —
Net Debt Issuance$0$0$0$0
Stock Repurchased$0$0$0-$5K
Dividends Paid$0$0$0$0
Other Financing$33M$57M$141M$175M
Financing Cash Flow$33M$57M$141M$175M
Net Change in Cash$18M$20M$63M$119M
Cash End of Period$20M$40M$103M$221M
Free Cash Flow-$15M-$38M-$72M-$56M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms